Filter
7181
Filtered Results: 7181
Text search:
Evidence
to
Action
Featured
Recommendations
618
New Publications
1877
Language
Document type
No document type
3942
Studies & Reports
1360
Guidelines
883
Manuals
374
Strategic & Response Plan
305
Fact sheets
122
Training Material
113
Situation Updates
40
Resource Platforms
19
Infographics
10
Brochures
7
Online Courses
5
App
1
Countries / Regions
Global
342
India
267
Kenya
200
Ethiopia
160
Western and Central Europe
148
South Africa
148
Sierra Leone
140
Uganda
137
Nigeria
133
Nepal
128
Latin America and the Carribbean
123
Myanmar / Burma
117
Liberia
111
Bangladesh
105
Malawi
100
Africa
91
Zambia
87
Tanzania
81
Rwanda
78
Ukraine
71
Syria
71
Ghana
67
Eastern Europe
61
Philippines
55
Namibia
53
South–East Asia Region
51
Congo, Democratic Republic of
50
Cambodia
44
Lesotho
42
Asia
42
South Sudan
42
Indonesia
42
Zimbabwe
41
Guinea
37
Mozambique
37
Venezuela
34
Russia
34
Middle East and North Africa
33
East and Southern Africa
33
Colombia
32
Senegal
30
Yemen
29
Haiti
28
Brazil
28
West and Central Africa
27
Eastern Europe and Central Asia
25
Pakistan
25
Botswana
24
Burkina Faso
22
Afghanistan
22
Germany
22
Cameroon
21
Eswatini/ Swaziland
21
Vietnam
20
Thailand
18
Jordan
16
Paraguay
16
Somalia
16
Chile
15
Sudan
14
Central African Republic
14
Peru
13
Lebanon
13
China
12
Laos
12
USA
12
Western Pacific Region
12
Ecuador
11
Benin
10
Argentina
10
Albania
9
Sri Lanka
9
Mexico
8
Turkey
8
Moldova
8
Tajikistan
7
Spain
7
Southern Africa
7
Angola
7
Madagascar
7
Iran
6
Palestine
6
Georgia
6
Libya
6
El Salvador
5
Malaysia
5
North America
5
Jamaica
5
United Kingdom
5
Bolivia
5
Mali
5
Iraq
5
Timor Leste/ East Timor
4
Serbia
4
Kyrgyzstan
4
Dominican Republic
4
Guinea-Bissau
4
Turkmenistan
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Greece
4
Honduras
4
Chad
4
Bhutan
4
North Macedonia
3
Kazakhstan
3
Fiji
3
Italy
3
Japan
3
Mauritius
3
Portugal
3
Bosnia and Herzegovina
3
Egypt
3
Gambia
2
Canada
2
Singapore
2
Burundi
2
Lithuania
2
Ireland
2
Saudi Arabia
2
Azerbaijan
2
Belarus
2
Israel
2
Guatemala
2
North Korea
1
Australia
1
Togo
1
Estonia
1
Niger
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Croatia
1
Gabon
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Tunisia
1
South Korea
1
Latvia
1
Nicaragua
1
Djibouti
1
Poland
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2534
Clinical Guidelines
499
Public Health
460
Women & Child Health
444
Key Resources
345
Capacity Building
131
Pharmacy & Technologies
47
Annual Report MEDBOX
1
Toolboxes
Mental Health
615
COVID-19
548
HIV
537
Planetary Health
348
TB
341
Disability
313
AMR
266
Caregiver
205
Conflict
184
Rapid Response
182
Global Health Education
159
Refugee
157
NCDs
155
Ebola
149
NTDs
142
Pharmacy
110
Natural Hazards
78
Health Financing Toolbox
75
Zika
52
Polio
45
Specific Hazards
37
Social Ethics
33
Cholera
28
Typhoon
3
Health Financing
2
South Sudan
1
This 400 page guide, created by PHI’s Center for Climate Change and Health and the American Public Health Association (APHA), with support from the California Department of Public Health helps local health departments prepare for and mitigate climate change effects—from drought and heat to flood...
Around the world, nurses are working under enormous pressure providing care to sick and dying patients during the pandemic. Many are faced with increased stress, and other negative effects on their mental health. They are also faced with the possibility of infection and death from COVID-19. Before t...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
It outlines key achievements, needs and opportunities for intervention in the field of rehabilitation in Ukraine. The content of this document is a snapshot in time – not an in-depth analysis of the entire rehabilitation sector. The analysis focuses on rehabilitation policy and governance, service...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
Women, girls and marginalized groups who are largely dependent on natural resources for livelihoods are among the hardest hit by extreme weather patterns. These weather patterns limit their access to food, water, shelter, education and access to essential health services, including those that addres...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
Climate change is one of the biggest crises of our time. Climate threats range from higher temperatures, heavy rainfalls and floods, erratic precipitation, droughts, desertification, and land degradation. This has negative implications on the quality and quantity of natural resources, such as land a...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
